Titan Medical Inc. Ordinary Shares
TMDI
TMDI was delisted on the 9th of March, 2023.
60 hedge funds and large institutions have $6.11M invested in Titan Medical Inc. Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 10 closing their positions.
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
27% more capital invested
Capital invested by funds: $4.82M → $6.11M (+$1.29M)
9% more funds holding
Funds holding: 55 → 60 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
+$1.72M |
| 2 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
+$259K |
| 3 |
Millennium Management
New York
|
+$224K |
| 4 |
Morgan Stanley
New York
|
+$170K |
| 5 |
VF
Virtu Financial
New York
|
+$88.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.28M |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$119K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$88K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$53K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$50.3K |
TMDI Hedge Fund Activity: Q2 2021 in Review
60 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Titan Medical Inc. Ordinary Shares (TMDI) for Q2 2021, worth a combined $6.11M — up 27% from $4.82M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new TMDI positions and 10 closed out — a net gain of 5 holders — while 13 added to existing stakes and 8 trimmed.
The largest buyer was Masters Capital Management, opening a new position worth an estimated $1.72M. The largest seller was Renaissance Technologies, cutting an estimated $1.28M.
- 60 institutional investors held Titan Medical Inc. Ordinary Shares (TMDI) as of Q2 2021, up from 55 in Q1 2021.
- Funds reported $6.11M of Titan Medical Inc. Ordinary Shares stock for Q2 2021, up 27% quarter-over-quarter.
- 15 funds opened new Titan Medical Inc. Ordinary Shares positions in Q2 2021 and 10 closed out, a net change of +5 holders.
- The largest Titan Medical Inc. Ordinary Shares buyer in Q2 2021 was Masters Capital Management, an estimated $1.72M added.
- The largest Titan Medical Inc. Ordinary Shares seller in Q2 2021 was Renaissance Technologies, an estimated $1.28M sold.
Based on aggregated 13F filings for Q2 2021.